Company Description
Nutra Pharma (OTC Link: NPHC) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $716.0K.
NPHC stock has declined 50.0% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, Nutra Pharma reported revenue of $246K with net income of -$1.3M and diluted earnings per share of $0.00. The company operates at a net profit margin of -522.0%.
This page provides a comprehensive overview of NPHC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nutra Pharma (NPHC) stock last traded at $0.0001. Over the past 12 months, the stock has lost 50.0%. At a market capitalization of $716.0K, NPHC is classified as a micro-cap stock with approximately 7.2B shares outstanding.
Latest News
Nutra Pharma has 7 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. View all NPHC news →
SEC Filings
Nutra Pharma has filed 4 recent SEC filings, including 3 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on March 25, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NPHC SEC filings →
Financial Highlights
Nutra Pharma generated $246K in revenue over the trailing twelve months, retaining a 65.6% gross margin, operating income reached -$878K (-356.6% operating margin), and net income was -$1.3M, reflecting a -522.0% net profit margin. Diluted earnings per share stood at $0.00. The company generated -$424K in operating cash flow. With a current ratio of 0.02, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
NPHC Company Profile & Sector Positioning
Nutra Pharma (NPHC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NPHC often look at related companies in the same sector, including Kaya Hldgs Inc (KAYS), Pharmadrug Inc (LMLLF), Maple Leaf Green (MGWFF), Adastra Holdings Ltd (XTXXF), and Cann American Corp (CNNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NPHC's relative position within its industry.